- Home
- AKRO vs SPNS Comparison
AKRO vs SPNS Comparison
Compare AKRO & SPNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- SPNS
- Stock Information
- Founded
- AKRO 2017
- SPNS 1982
- Country
- AKRO United States
- SPNS Israel
- Employees
- AKRO N/A
- SPNS 4850
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- SPNS Computer Software: Prepackaged Software
- Sector
- AKRO Health Care
- SPNS Technology
- Exchange
- AKRO Nasdaq
- SPNS Nasdaq
- Market Cap
- AKRO 3.6B
- SPNS 2.4B
- IPO Year
- AKRO 2019
- SPNS 1992
- Fundamental
- Price
- AKRO $44.53
- SPNS $43.02
- Analyst Decision
- AKRO Strong Buy
- SPNS Hold
- Analyst Count
- AKRO 8
- SPNS 3
- Target Price
- AKRO $80.38
- SPNS $31.33
- AVG Volume (30 Days)
- AKRO 915.6K
- SPNS 781.3K
- Earning Date
- AKRO 11-07-2025
- SPNS 11-10-2025
- Dividend Yield
- AKRO N/A
- SPNS 1.39%
- EPS Growth
- AKRO N/A
- SPNS N/A
- EPS
- AKRO N/A
- SPNS 1.22
- Revenue
- AKRO N/A
- SPNS $549,037,000.00
- Revenue This Year
- AKRO N/A
- SPNS $8.50
- Revenue Next Year
- AKRO N/A
- SPNS $6.83
- P/E Ratio
- AKRO N/A
- SPNS $35.28
- Revenue Growth
- AKRO N/A
- SPNS 3.08
- 52 Week Low
- AKRO $21.34
- SPNS $23.69
- 52 Week High
- AKRO $58.40
- SPNS $43.17
- Technical
- Relative Strength Index (RSI)
- AKRO 45.51
- SPNS 83.40
- Support Level
- AKRO $41.80
- SPNS $42.95
- Resistance Level
- AKRO $45.44
- SPNS $43.18
- Average True Range (ATR)
- AKRO 1.97
- SPNS 0.12
- MACD
- AKRO -0.04
- SPNS -0.49
- Stochastic Oscillator
- AKRO 48.82
- SPNS 52.94
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About SPNS Sapiens International Corporation N.V. (Cayman Islands)
Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.